Jefferies Group’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$2.46M Sell
31,002
-424,343
-93% -$33.7M 0.02% 294
2022
Q2
$33.8M Sell
455,345
-273,672
-38% -$20.3M 0.28% 13
2022
Q1
$65.5M Buy
729,017
+665,200
+1,042% +$59.8M 0.41% 4
2021
Q4
$7.14M Sell
63,817
-266,433
-81% -$29.8M 0.04% 147
2021
Q3
$41.5M Hold
330,250
0.3% 9
2021
Q2
$44.7M Sell
330,250
-144,250
-30% -$19.5M 0.28% 16
2021
Q1
$64.4M Buy
474,500
+414,500
+691% +$56.2M 0.56% 4
2020
Q4
$8.45M Sell
60,000
-58,005
-49% -$8.17M 0.07% 125
2020
Q3
$13.1M Sell
118,005
-73,798
-38% -$8.22M 0.15% 43
2020
Q2
$21.5K Buy
191,803
+77,706
+68% +$8.7K 0.25% 14
2020
Q1
$8.84M Buy
114,097
+65,443
+135% +$5.07M 0.1% 76
2019
Q4
$4.63M Sell
48,654
-142,335
-75% -$13.5M 0.04% 260
2019
Q3
$14.6M Buy
190,989
+86,809
+83% +$6.62M 0.11% 32
2019
Q2
$9.14M Buy
104,180
+52,000
+100% +$4.56M 0.07% 71
2019
Q1
$4.72M Sell
52,180
-27,575
-35% -$2.5M 0.04% 180
2018
Q4
$5.72M Sell
79,755
-22,425
-22% -$1.61M 0.05% 137
2018
Q3
$9.8M Buy
102,180
+100,000
+4,587% +$9.59M 0.06% 82
2018
Q2
$208K Sell
2,180
-900
-29% -$85.9K ﹤0.01% 1331
2018
Q1
$270K Buy
3,080
+900
+41% +$78.9K ﹤0.01% 1188
2017
Q4
$185K Sell
2,180
-800
-27% -$67.9K ﹤0.01% 1492
2017
Q3
$258K Sell
2,980
-31,500
-91% -$2.73M ﹤0.01% 1249
2017
Q2
$2.66M Buy
34,480
+32,300
+1,482% +$2.49M 0.02% 394
2017
Q1
$151K Sell
2,180
-75,698
-97% -$5.24M ﹤0.01% 1340
2016
Q4
$4.61M Buy
77,878
+76,728
+6,672% +$4.54M 0.03% 208
2016
Q3
$76K Sell
1,150
-81,715
-99% -$5.4M ﹤0.01% 1169
2016
Q2
$4.48M Sell
82,865
-12,390
-13% -$670K 0.02% 137
2016
Q1
$4.92M Buy
95,255
+94,505
+12,601% +$4.88M 0.03% 129
2015
Q4
$53K Sell
750
-46,540
-98% -$3.29M ﹤0.01% 1195
2015
Q3
$2.94M Buy
47,290
+46,540
+6,205% +$2.9M 0.02% 267
2015
Q2
$63K Buy
+750
New +$63K ﹤0.01% 1489
2015
Q1
Hold
0
1557
2014
Q4
Sell
-750
Closed -$39K 1552
2014
Q3
$39K Buy
+750
New +$39K ﹤0.01% 1292